Our results indicate that the JAK/STAT3 pathway is involved in the immunoregulation of BM-MSCs, and provide critical insight into the development of novel targeted therapies against periodontitis and perhaps also other inflammation/immune disorder-related diseases. Here, STAT3 is linked to periodontitis.